Anesthesiology, Pain Medicine · Eustis, FL
NPI
1194778852
Since 2006
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
601 Jennings Ave
Eustis, FL, 32726
Phone (352) 357-0668
Medicare paid, 2024
$639K
11,469 services
Medicare patients, 2024
403
Average age 71
Drug cost, 2024
$519K
11,756 prescriptions
Company payments, 2025
$378
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nathan J Hanflink was code 99439 (chronic, principal, and transitional care management), 3,640 times for 276 patients. In total Nathan J Hanflink billed 11,469 services in 22 codes, and Medicare paid $639K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-21.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99439 Chronic, Principal, and Transitional Care Management | Office | 3,640 | 276 | $36.31 | $132K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,949 | 276 | $47.33 | $92K |
| 99213 Office E&M - Established | Office | 1,456 | 334 | $64.26 | $94K |
| 99214 Office E&M - Established | Office | 1,415 | 296 | $91.32 | $129K |
| 80307 Drug Tests | Office | 712 | 248 | $60.83 | $43K |
| 96132 Behavioral Health Services | Office | 590 | 242 | $90.12 | $53K |
| 96138 Behavioral Health Services | Office | 508 | 235 | $24.13 | $12K |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 347 | 61 | $5.48 | $1,902 |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 319 | 166 | $54.94 | $18K |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 288 | 166 | $102.69 | $30K |
| 62323 Nerve Block Injection - Back | Office | 105 | 39 | $183.52 | $19K |
| 99204 Office E&M - New | Office | 58 | 58 | $129.88 | $7,533 |
| 99203 Office E&M - New | Office | 26 | 26 | $57.79 | $1,503 |
By year: 2022 $268K for 4,181 services; 2023 $343K for 5,192 services; 2024 $639K for 11,469 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 712 | 248 | $60.83 | $43K |
Medicare prescription drug claims, 2024
In 2024, the drug Nathan J Hanflink prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 3,604 prescriptions and refills. In total Nathan J Hanflink wrote 11,756 Medicare prescriptions that cost $519K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 3,604 | 3,606 | 465 | $119K |
| Oxycodone Hcl Generic | 1,794 | 1,794 | 207 | $34K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,760 | 1,760 | 200 | $74K |
| Morphine Sulfate Er Morphine Sulfate | 1,188 | 1,188 | 122 | $43K |
| Tramadol Hcl Generic | 589 | 589 | 125 | $6,777 |
| Gabapentin Generic | 517 | 575 | 78 | $7,513 |
| Pregabalin Generic | 328 | 346 | 89 | $9,997 |
| Cyclobenzaprine Hcl Generic | 299 | 313 | 70 | $3,145 |
| Fentanyl Generic | 288 | 288 | 28 | $26K |
| Tizanidine Hcl Generic | 218 | 270 | 37 | $2,728 |
| Methadone Hcl Generic | 210 | 210 | 25 | $4,397 |
| Morphine Sulfate Generic | 167 | 167 | 19 | $4,946 |
| Hydromorphone Hcl Generic | 158 | 158 | 16 | $3,623 |
| Baclofen Generic | 119 | 135 | 19 | $1,348 |
| Methocarbamol Generic | 52 | 66 | 15 | $1,444 |
Brand drugs: 203 claims; generic drugs: 11,553 claims; opioid claims: 10,002.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nathan J Hanflink $378 ($378 in general payments such as food, travel and fees) from 2 companies. The largest payer was Boston Scientific Corporation with $306.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 3 | $306 |
| Protega Pharmaceutials Inc | 1 | $72.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.